Utah 2026 General Session Status: Enacted 2 R cosponsors

SB 83 — Controlled Substance Scheduling Amendments

Last action — Governor Signed

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced January 06, 2026. Enacted.

Signed by Governor Spencer Cox (Republican) on March 24, 2026.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 54% · moderate confidence

  • Enacted

    Current position in the legislative process.

  • 2 sponsors

    1 primary, 1 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (2 R).

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Bill Text

What changed in the latest version

429 added · 434 removed

Plain-language change summary

The recent amendments to Bill SB 83 include the addition of specific substances related to cannabis and altered chemical names for controlled drugs, such as 4-methoxyamphetamine. This change clarifies which synthetic equivalents and derivatives of cannabis are regulated, ensuring that laws keep pace with evolving drug formulations. By updating the language, the bill aims to enhance safety and provide clearer guidelines for law enforcement and public health regarding drug classification.

→
Previous
Latest
02-25 11:18 S.B.
Enrolled Copy S.B.
(2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by.the official name, common or usual name, chemical name, or brand name designated:
(2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by the official name, common or usual name, chemical name, or brand name designated:
B .
8 (i) Unless specifically excepted or unless listed in another schedule, any of the 3 following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific chemical designation:
(i) Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of S.B.
S.B.
83 Enrolled Copy isomers, esters, and ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific chemical designation:
83 02-25 11:18 (A) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
(A) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
(Z) Dimenoxadol;
- 2 - Enrolled Copy S.B.
83 (Z) Dimenoxadol;
- 2 - 02-25 11:18 S.B.
(BB) Dimethylthiambutene;
83 (BB) Dimethylthiambutene;
(CCC) Phenoperidine;
(DDD) Piritramide;
83 02-25 11:18 (EEE) Proheptazine;
83 Enrolled Copy (CCC) Phenoperidine;
(DDD) Piritramide;
(EEE) Proheptazine;
(L) Hydromorphinol;
- 4 - Enrolled Copy S.B.
83 (L) Hydromorphinol;
- 4 - 02-25 11:18 S.B.
(N) Methylhydromorphine;
83 (N) Methylhydromorphine;
(J) 3,4-methylenedioxymethamphetamine (MDMA);
- 5 - S.B.
(K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl- - 5 - S.B.
83 Enrolled Copy (J) 3,4-methylenedioxymethamphetamine (MDMA);
83 02-25 11:18 alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
(K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl- alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
(AA) Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis (cannabis plant), except for marijuana as defined in Subsection 58-37-2 (1)(aa)(i)(E), as well as synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of Cannabis, sp.
(AA) Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis (cannabis plant), except for marijuana as defined in Subsection 58-37-2(1)(aa)(i)(E), as well as synthetic equivalents of the substances - 6 - Enrolled Copy S.B.
and/or synthetic substances, derivatives, and their isomers with similar chemical structure and - 6 - 02-25 11:18 S.B.
83 contained in the cannabis plant, or in the resinous extractives of Cannabis, sp.
83 pharmacological activity to those substances contained in the plant, such as the following:
and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:
alpha-(methylamino)propiophenone;
- 7 - S.B.
83 Enrolled Copy alpha-(methylamino)propiophenone;
AL-463 and UR1432, - 7 - S.B.
AL-463 and UR1432, its salts, optical isomers, and salts of optical isomers;
83 02-25 11:18 its salts, optical isomers, and salts of optical isomers;
(X) Hydrocodone;
- 8 - Enrolled Copy S.B.
83 (X) Hydrocodone;
- 8 - 02-25 11:18 S.B.
(XIII) Morphine;
83 (XIII) Morphine;
(H) Diphenoxylate;
- 9 - S.B.
83 Enrolled Copy (H) Diphenoxylate;
- 9 - S.B.
(K) Levo-alphacetylmethadol, some other names:
83 02-25 11:18 (K) Levo-alphacetylmethadol, some other names:
(A) Amobarbital;
- 10 - Enrolled Copy S.B.
83 (A) Amobarbital;
- 10 - 02-25 11:18 S.B.
(D) Phencyclidine;
Show all 72 changed rows (32 more)
Previous
Latest
83 (D) Phencyclidine;
(D) Clortermine;
- 11 - S.B.
83 Enrolled Copy (D) Clortermine;
(ii) Unless specifically excepted or unless listed in another schedule, any material, - 11 - S.B.
(ii) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:
83 02-25 11:18 compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:
Food and Drug Administration approved drug product, some other names for dronabinol:
Food and Drug Administration approved drug product, some other names - 12 - Enrolled Copy S.B.
83 for dronabinol:
- 12 - 02-25 11:18 S.B.
(iv) Nalorphine.
83 (iv) Nalorphine.
(vi) Unless specifically excepted or unless listed in another schedule, anabolic steroids including any of the following or any isomer, ester, salt, or derivative of the following that promotes muscle growth:
(vi) Unless specifically excepted or unless listed in another schedule, anabolic steroids including any of the following or any isomer, ester, salt, or derivative of - 13 - S.B.
83 Enrolled Copy the following that promotes muscle growth:
- 13 - S.B.
(C) Clostebol;
83 02-25 11:18 (C) Clostebol;
(viii) A drug product or preparation that contains any component of marijuana, including tetrahydrocannabinol, and is approved by the United States Food and Drug Administration and scheduled by the Drug Enforcement Administration in Schedule III of the federal Controlled Substances Act, Title II, P.L.
(viii) A drug product or preparation that contains any component of marijuana, including tetrahydrocannabinol, and is approved by the United States Food and Drug Administration and scheduled by the Drug Enforcement Administration in - 14 - Enrolled Copy S.B.
83 Schedule III of the federal Controlled Substances Act, Title II, P.L.
- 14 - 02-25 11:18 S.B.
(i) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.
83 (i) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.
(W) Flunitrazepam;
- 15 - S.B.
83 Enrolled Copy (W) Flunitrazepam;
- 15 - S.B.
(Z) Haloxazolam;
83 02-25 11:18 (Z) Haloxazolam;
(iii) Any material, compound, mixture, or preparation of fenfluramine which contains any quantity of the following substances, including its salts, isomers whether optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of isomers is possible.
(iii) Any material, compound, mixture, or preparation of fenfluramine which contains any quantity of the following substances, including its salts, isomers whether - 16 - Enrolled Copy S.B.
(iv) Unless specifically excepted or unless listed in another schedule, any material, - 16 - 02-25 11:18 S.B.
83 optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of isomers is possible.
83 compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers whether optical, position, or geometric isomers, and salts of the isomers when the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation:
(iv) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers whether optical, position, or geometric isomers, and salts of the isomers when the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation:
(A) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
(B) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;
83 02-25 11:18 (C) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;
83 Enrolled Copy (A) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
(B) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;
(C) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;
(3) Ĥ→ (a) As used in this subsection, "pharmaceutical composition" means a drug 591a that has United States Food and Drug Administration approval under 21 U.S.C.
(3)(a) As used in this subsection, "pharmaceutical composition" means a drug that has United States Food and Drug Administration approval under 21 U.S.C.
591b 355 following clinical trials.
355 following clinical trials.
591c (b) ←Ĥ If the federal government schedules Ĥ→ [the] ←Ĥ Ĥ→ a ←Ĥ pharmaceutical 591d composition of a Schedule I controlled substance or Ĥ→ [the] ←Ĥ Ĥ→ a ←Ĥ pharmaceutical composition of any form 592a of a Schedule I controlled substance in a schedule that is not Schedule I, that Ĥ→ pharmaceutical ←Ĥ 593a composition is deemed scheduled under this section in the same schedule that the Ĥ→ pharmaceutical ←Ĥ 594a composition is scheduled under 21 U.S.C.
(b) If the federal government schedules a pharmaceutical composition of a Schedule I controlled substance or a pharmaceutical composition of any form of a Schedule I controlled substance in a schedule that is not Schedule I, that pharmaceutical composition is deemed scheduled under this section in the same schedule that the pharmaceutical composition is scheduled under 21 U.S.C.
⬇ Download PDF
View plain text versions (4)

Amendments

1 amendment

Click Show changes on an amendment above to see how it modifies the bill.

Action History

  1. Governor Signed

  2. Senate/ to Governor

  3. Senate/ received enrolled bill from Printing

  4. Senate/ enrolled bill to Printing

  5. Enrolled Bill Returned to House or Senate

  6. Draft of Enrolled Bill Prepared

  7. Bill Received from Senate for Enrolling

  8. Senate/ signed by President/ sent for enrolling

  9. Senate/ received from House

  10. House/ to Senate

  11. House/ signed by Speaker/ returned to Senate

  12. House/ received from Senate

  13. Senate/ to House

  14. Senate/ concurs with House amendment

  15. Senate/ placed on Concurrence Calendar

  16. Senate/ received from House

  17. House/ to Senate

  18. House/ passed 3rd reading

  19. House/ floor amendment

  20. House/ 3rd reading

  21. House/ 2nd reading

  22. House/ committee report favorable [House Health and Human Services Committee]

  23. House Comm - Favorable Recommendation [House Health and Human Services Committee]

  24. House/ to standing committee [House Health and Human Services Committee]

  25. House/ 1st reading (Introduced)

  26. House/ received from Senate

  27. Senate/ to House

  28. Senate/ passed 3rd reading

  29. Senate/ 3rd reading

  30. Senate/ passed 2nd reading

  31. Senate/ 2nd reading

  32. Senate/ placed on 2nd Reading Calendar

  33. Senate/ committee report favorable [Senate Health and Human Services Committee]

  34. Senate Comm - Favorable Recommendation [Senate Health and Human Services Committee]

  35. Senate/ to standing committee [Senate Health and Human Services Committee]

  36. Senate/ received fiscal note from Fiscal Analyst

  37. LFA/ fiscal note publicly available for SB0083

  38. Senate/ 1st reading (Introduced)

  39. LFA/ fiscal note sent to sponsor for SB0083

  40. Senate/ received bill from Legislative Research

  41. LFA/ bill sent to agencies for fiscal input for SB0083

  42. LFA/ bill assigned to staff for fiscal analysis for SB0083

  43. Numbered Bill Publicly Distributed

  44. Bill Numbered but not Distributed

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 1 co-sponsors · 102 not signed on

Sponsors (1)

Co-sponsors (1)

Not signed on (102)

102 members have not signed on to this bill.

Show all 102 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 83?
SB 83 is sponsored by Logan Monson (Republican) and Evan J. Vickers (Republican).
What is the current status of SB 83?
This bill has been enacted into law. Introduced January 06, 2026. Enacted.
Where can I track SB 83?
Track SB 83 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 83

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 83

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →